Philadelphia, PA – Thermo Electron Corporation,that WuXi PharmaTech Co., Ltd., the leader in the pharmaceutical R&D services industry in China, has selected Watson LIMS to meet the specific data management requirements of its bioanalytical facilities.
Shanghai-based WuXi PharmaTech serves 19 of the top 20 pharmaceutical companies and 8 of the top 10 biopharmaceutical companies in the world, helping them to shorten the cycle and lower the cost of drug research and development. WuXi provides discovery and development services, from lead identification to pre-clinical, at its state-of-the-art facilities.
Watson is the industry leading laboratory information management system (LIMS) for bioanalytical labs. As a purpose-built, commercial-off-the-shelf solution, Watson promotes compliance with Good Laboratory Practices (GLP) regulations and 21 CFR Part 11 guidance from the U.S. Food and Drug Administration (FDA). Watson is relied on by 18 of the top 20 global pharmaceutical organizations, and is widely used in leading biotechnology and contract research organizations worldwide.
Watson is part of Thermo’s pharmaceutical suite of informatics solutions. Thermo’s purpose-built solutions include Nautilus LIMS for research and development, particularly in biotechnology; Galileo LIMS for in vitro ADME/Tox research; Watson for bioanalysis; and Darwin LIMS for pharmaceutical manufacturing R&D and quality control. Thermo also provides the Enterprise Pharmacology (EP) Series and Kinetica as dedicated DMPK analysis tools, GRAMS/AI for spectral data processing, and Atlas CDS, selected a top chromatography data system in 2005.